These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 7512163)

  • 1. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans.
    Shirai M; Okada H; Nishioka M; Akatsuka T; Wychowski C; Houghten R; Pendleton CD; Feinstone SM; Berzofsky JA
    J Virol; 1994 May; 68(5):3334-42. PubMed ID: 7512163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein.
    Shirai M; Akatsuka T; Pendleton CD; Houghten R; Wychowski C; Mihalik K; Feinstone S; Berzofsky JA
    J Virol; 1992 Jul; 66(7):4098-106. PubMed ID: 1376366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region.
    Kurokohchi K; Akatsuka T; Pendleton CD; Takamizawa A; Nishioka M; Battegay M; Feinstone SM; Berzofsky JA
    J Virol; 1996 Jan; 70(1):232-40. PubMed ID: 8523531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.
    Koziel MJ; Dudley D; Afdhal N; Choo QL; Houghton M; Ralston R; Walker BD
    J Virol; 1993 Dec; 67(12):7522-32. PubMed ID: 7693974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
    Shirai M; Arichi T; Nishioka M; Nomura T; Ikeda K; Kawanishi K; Engelhard VH; Feinstone SM; Berzofsky JA
    J Immunol; 1995 Mar; 154(6):2733-42. PubMed ID: 7533182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.
    Sarobe P; Pendleton CD; Akatsuka T; Lau D; Engelhard VH; Feinstone SM; Berzofsky JA
    J Clin Invest; 1998 Sep; 102(6):1239-48. PubMed ID: 9739058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the Ld-restricted cytotoxic T-lymphocyte epitope in the mouse hepatitis virus nucleocapsid protein.
    Bergmann C; McMillan M; Stohlman S
    J Virol; 1993 Dec; 67(12):7041-9. PubMed ID: 7693965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines.
    Shirai M; Chen M; Arichi T; Masaki T; Nishioka M; Newman M; Nakazawa T; Feinstone SM; Berzofsky JA
    J Infect Dis; 1996 Jan; 173(1):24-31. PubMed ID: 8537666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules.
    Battegay M; Fikes J; Di Bisceglie AM; Wentworth PA; Sette A; Celis E; Ching WM; Grakoui A; Rice CM; Kurokohchi K
    J Virol; 1995 Apr; 69(4):2462-70. PubMed ID: 7884894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
    Shi L; Liu S; Fan GX; Sheng L; Ren HX; Yuan YK
    Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the epitopes on HCV core protein recognized by HLA-A2 restricted cytotoxic T lymphocytes.
    Zhou HC; Xu DZ; Wang XP; Zhang JX; Huang Y; Yan YP; Zhu Y; Jin BQ
    World J Gastroenterol; 2001 Aug; 7(4):583-6. PubMed ID: 11819836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helper T cell determinant peptide contributes to induction of cellular immune responses by peptide vaccines against hepatitis C virus.
    Hiranuma K; Tamaki S; Nishimura Y; Kusuki S; Isogawa M; Kim G; Kaito M; Kuribayashi K; Adachi Y; Yasutomi Y
    J Gen Virol; 1999 Jan; 80 ( Pt 1)():187-193. PubMed ID: 9934701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patr-A and B, the orthologues of HLA-A and B, present hepatitis C virus epitopes to CD8+ cytotoxic T cells from two chronically infected chimpanzees.
    Kowalski H; Erickson AL; Cooper S; Domena JD; Parham P; Walker CM
    J Exp Med; 1996 Apr; 183(4):1761-75. PubMed ID: 8666933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization.
    Hu GJ; Wang RY; Han DS; Alter HJ; Shih JW
    Vaccine; 1999 Aug; 17(23-24):3160-70. PubMed ID: 10462252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.
    Missale G; Redeker A; Person J; Fowler P; Guilhot S; Schlicht HJ; Ferrari C; Chisari FV
    J Exp Med; 1993 Mar; 177(3):751-62. PubMed ID: 7679709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
    Cerny A; McHutchison JG; Pasquinelli C; Brown ME; Brothers MA; Grabscheid B; Fowler P; Houghton M; Chisari FV
    J Clin Invest; 1995 Feb; 95(2):521-30. PubMed ID: 7860734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
    Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
    J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes.
    Kuhröber A; Wild J; Pudollek HP; Chisari FV; Reimann J
    Int Immunol; 1997 Aug; 9(8):1203-12. PubMed ID: 9263018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection.
    Koziel MJ; Walker BD
    Springer Semin Immunopathol; 1997; 19(1):69-83. PubMed ID: 9266632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.
    Koziel MJ; Dudley D; Afdhal N; Grakoui A; Rice CM; Choo QL; Houghton M; Walker BD
    J Clin Invest; 1995 Nov; 96(5):2311-21. PubMed ID: 7593618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.